How about the bigger picture? The company is about
Post# of 223
The stock jumped after their PII results because the product works! BPX-01 reduced facial P. acnes by more than 90% after four weeks of use in the trial, representing a statistically significant average over the control.
Not too mention, their patent was just approved.
"BPX-04 is the company's latest addition to its clinical pipeline. It is the second product built on the proprietary, patent BioPharmX hydrophilic topical delivery system."
Over 50% institutional investors hold this stock, and have been holding! This is a multi-bagger investment, and the sleeping giant is about to awake!